NCT05684770View on ClinicalTrials.gov

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
Thromboembolic Disease
Interventions
OTHER

4G tablet

Participants will receive for the whole period of study a 4G tablet in order to fill questionnaires, learn information about their drugs (patient education), have a remote consultation and evaluate treatment compliance.

Trial Locations (1)

27000

RECRUITING

Centre Hospitalier Eure-Seine, Évreux

All Listed Sponsors
lead

Centre Hospitalier Eure-Seine

OTHER

NCT05684770 - Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk | Biotech Hunter | Biotech Hunter